Announced Mon, 8 Jun · 13:02 IST

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sudhir Sethi

Promoter Stake BuyOwnership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+6.2%1-day move

₹22.84

prior close

₹24.01

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.0+0.0+0.0+6.2+6.2+0.9-1.1+2.9-1.6-2.8+3.6——

Up moveDown movePending

AI summary

Mr. Sudhir Sethi, a main promoter of Beryl Drugs Ltd, has purchased 1,992 equity shares (0.03% of total share capital) through open market transactions on 05-06-2026. His holding increased from 4,93,983 shares (9.72%) to 4,95,975 shares (9.75%). The total equity share capital of the company remains at 50,71,700 shares. The disclosure was filed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

Likely market impact

This is a minor open-market purchase by a promoter that signals modest insider confidence, though the increase is very small (0.03%) and unlikely to materially move the stock price. Sudhir Sethi's stake is now approaching the 10% disclosure threshold, which could trigger further disclosures if acquisitions continue.